| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 541 | 3.093 | 2.536 | 5.270 | 6.356 | 10.005 | 38.814 | 47.370 | 44.551 |
| Total Income - EUR | - | 541 | 3.093 | 2.536 | 5.270 | 6.356 | 10.005 | 38.814 | 47.370 | 44.552 |
| Total Expenses - EUR | - | 85 | 1.636 | 1.514 | 837 | 2.975 | 9.566 | 17.247 | 23.322 | 31.779 |
| Gross Profit/Loss - EUR | - | 456 | 1.457 | 1.022 | 4.433 | 3.381 | 439 | 21.567 | 24.048 | 12.773 |
| Net Profit/Loss - EUR | - | 440 | 1.364 | 946 | 4.275 | 3.196 | 327 | 21.179 | 23.575 | 11.437 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Nibas Therapy Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 233 | 0 | 0 | 0 | 0 | 1.971 | 7.534 | 7.637 | 6.003 |
| Current Assets | - | 520 | 2.153 | 2.710 | 6.988 | 10.067 | 8.720 | 20.702 | 28.359 | 7.595 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 3.011 | 4.716 | 4.690 |
| Receivables | - | 111 | 219 | 0 | 316 | 552 | 0 | 16.255 | 16.885 | 291 |
| Cash | - | 409 | 1.934 | 2.710 | 6.672 | 9.515 | 8.720 | 1.436 | 6.757 | 2.613 |
| Shareholders Funds | - | 485 | 1.841 | 2.753 | 6.974 | 10.037 | 10.142 | 21.228 | 23.623 | 11.485 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 320 | 345 | 50 | 75 | 58 | 549 | 7.009 | 12.373 | 2.113 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8695 - 8695" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Nibas Therapy Srl